Cargando…

An overview of Ebola virus disease

Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush me...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadanali, Ayten, Karagoz, Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175058/
https://www.ncbi.nlm.nih.gov/pubmed/28058346
http://dx.doi.org/10.14744/nci.2015.97269
_version_ 1782484585841426432
author Kadanali, Ayten
Karagoz, Gul
author_facet Kadanali, Ayten
Karagoz, Gul
author_sort Kadanali, Ayten
collection PubMed
description Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat. EVD has an incubation period of 2 to 21 days, and the infection has an acute onset without any carrier status. Currently, there is no standard treatment for EVD, so it is important to avoid infection or further spreading of the virus. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. Its treatment involves early, aggressive supportive care with rehydration. Clinicians should consider the possibility of EVD in persons with travel or exposure history with the incubation period presenting constitutional symptoms in order to promptly identify diseased patients, and prevent further spreading of the disease.
format Online
Article
Text
id pubmed-5175058
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-51750582017-01-05 An overview of Ebola virus disease Kadanali, Ayten Karagoz, Gul North Clin Istanb Review Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat. EVD has an incubation period of 2 to 21 days, and the infection has an acute onset without any carrier status. Currently, there is no standard treatment for EVD, so it is important to avoid infection or further spreading of the virus. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. Its treatment involves early, aggressive supportive care with rehydration. Clinicians should consider the possibility of EVD in persons with travel or exposure history with the incubation period presenting constitutional symptoms in order to promptly identify diseased patients, and prevent further spreading of the disease. Kare Publishing 2015-04-24 /pmc/articles/PMC5175058/ /pubmed/28058346 http://dx.doi.org/10.14744/nci.2015.97269 Text en Copyright: © Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Review
Kadanali, Ayten
Karagoz, Gul
An overview of Ebola virus disease
title An overview of Ebola virus disease
title_full An overview of Ebola virus disease
title_fullStr An overview of Ebola virus disease
title_full_unstemmed An overview of Ebola virus disease
title_short An overview of Ebola virus disease
title_sort overview of ebola virus disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175058/
https://www.ncbi.nlm.nih.gov/pubmed/28058346
http://dx.doi.org/10.14744/nci.2015.97269
work_keys_str_mv AT kadanaliayten anoverviewofebolavirusdisease
AT karagozgul anoverviewofebolavirusdisease
AT kadanaliayten overviewofebolavirusdisease
AT karagozgul overviewofebolavirusdisease